Using a Delphi process to determine optimal care for patients with pancreatic cancer
Elizabeth A Burmeister, Susan J Jordan, Dianne L O'Connell, Vanessa L Beesley, David Goldstein, Helen M Gooden, Monika Janda, Neil D Merrett, David Wyld, Rachel E Neale
Asia-Pacific Journal of Clinical Oncology | WILEY | Published : 2016
AIM: Overall 5-year survival for pancreatic cancer is ∼5%. Optimizing the care that pancreatic cancer patients receive may be one way of improving outcomes. The objective of this study was to establish components of care which Australian health professionals believe important to optimally manage patients with pancreatic cancer. METHODS: Using a Delphi process, a multidisciplinary panel of 250 health professionals were invited to provide a list of factors they considered important for optimal care of pancreatic cancer patients. They were then asked to score and then rescore (from one [no importance/disagree] to 10 [very important/agree]) the factors. The mean and coefficient of variation scor..View full abstract
Awarded by National Health and Medical Research Council (NHMRC) (Australia)
This study was funded by a National Health and Medical Research Council (NHMRC) (Australia) project grant (#613654) and has been conducted with full ethical approval. R. Neale and S. Jordan are funded by NHMRC fellowships and E. Burmeister by a NHMRC scholarship. We thank the contribution of the pancreatic cancer clinical working group and the health professionals who participated in the Delphi process.